Literature DB >> 3016979

Morphology of a GHRH producing pancreatic islet cell tumour causing acromegaly.

W Saeger, H M Schulte, G Klöppel.   

Abstract

A 54 year old woman suffered from acromegaly due to a pancreatic islet cell tumour producing GHRH. The tumour was demonstrated on CT scan. The diagnosis was established from elevated plasma levels of GHRH, GH and prolactin, and by the lack of signs of a pituitary adenoma in trans-sphenoidal surgery. Acromegaly was cured by tumour removal. Light microscopically, the tumour showed a medullary and microlobular pattern. The cells were large and often cuspidal. Small granules were found in semi-thin sections. Small aggregations of amyloid fibres were seen, mostly around capillaries. Immunocytochemistry revealed GHRH, NSE, neurotensin, serotonin, VIP and PP. S 100 was positive only in nerve fibres. Staining for GH, ACTH, calcitonin, alpha-HCG, beta-HCG, insulin, glucagon, gastrin, substance P, bombesin and somatostatin was negative. Ultrastructure showed oval partly lobulated nuclei with small nucleoli, moderate amounts of rough endoplasmic reticulum, many free ribosomes, some large Golgi fields and small numbers of secretory granules measuring 150 nm or, in a few cells, 650 nm. Only 4 other cases of pancreatic endocrine tumours causing acromegaly by ectopic GHRH secretion are described in the literature and these were similar to our case in many respects.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3016979     DOI: 10.1007/bf00705425

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  17 in total

1.  Eosinophilic adenoma of the pituitary and carcinoid tumor of the rectosigmoid area.

Authors:  J BUSE; M G BUSE; W J ROBERTS
Journal:  J Clin Endocrinol Metab       Date:  1961-06       Impact factor: 5.958

2.  Acromegaly due to secretion of growth hormone by an ectopic pancreatic islet-cell tumor.

Authors:  S Melmed; C Ezrin; K Kovacs; R S Goodman; L A Frohman
Journal:  N Engl J Med       Date:  1985-01-03       Impact factor: 91.245

3.  Intracranial dissemination of pituitary adenomas.

Authors:  K M Ogilvy; J Jakubowski
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-04       Impact factor: 10.154

4.  Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour.

Authors:  J Rivier; J Spiess; M Thorner; W Vale
Journal:  Nature       Date:  1982-11-18       Impact factor: 49.962

5.  Somatoliberinoma: morphologic characteristics.

Authors:  K Kovacs; N Ryan; E Horvath; S L Asa; M O Thorner; D A Leong; W Vale; J Rivier; B W Scheithauer; R V Randall
Journal:  Arch Pathol Lab Med       Date:  1984-05       Impact factor: 5.534

6.  A case for hypothalamic acromegaly: a clinicopathological study of six patients with hypothalamic gangliocytomas producing growth hormone-releasing factor.

Authors:  S L Asa; B W Scheithauer; J M Bilbao; E Horvath; N Ryan; K Kovacs; R V Randall; E R Laws; W Singer; J A Linfoot
Journal:  J Clin Endocrinol Metab       Date:  1984-05       Impact factor: 5.958

7.  Multihormonal carcinoid tumor of the pancreas. Secreting growth hormone-releasing factor as a cause of acromegaly.

Authors:  G Berger; J Trouillas; B Bloch; G Sassolas; F Berger; C Partensky; J A Chayvialle; P Brazeau; B Claustrat; F Lesbros
Journal:  Cancer       Date:  1984-11-15       Impact factor: 6.860

8.  Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor.

Authors:  M O Thorner; R L Perryman; M J Cronin; A D Rogol; M Draznin; A Johanson; W Vale; E Horvath; K Kovacs
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

9.  Growth-hormone-releasing factor immunoreactivity in human endocrine tumors.

Authors:  D G Bostwick; R Quan; A R Hoffman; R J Webber; J K Chang; K G Bensch
Journal:  Am J Pathol       Date:  1984-11       Impact factor: 4.307

10.  Failure to respond to growth hormone releasing hormone (GHRH) in acromegaly due to a GHRH secreting pancreatic tumor: dynamics of multiple endocrine testing.

Authors:  H M Schulte; G Benker; R Windeck; T Olbricht; D Reinwein
Journal:  J Clin Endocrinol Metab       Date:  1985-09       Impact factor: 5.958

View more
  4 in total

1.  NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas.

Authors:  Matthew H Kulke; Lowell B Anthony; David L Bushnell; Wouter W de Herder; Stanley J Goldsmith; David S Klimstra; Stephen J Marx; Janice L Pasieka; Rodney F Pommier; James C Yao; Robert T Jensen
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

2.  Growth hormone-releasing hormone (GRH)-producing pancreatic tumor with no evidence of multiple endocrine neoplasia type 1.

Authors:  S Kawa; T Ueno; A Iijima; T Midorikawa; Y Fujimori; M Tokoo; H Oguchi; K Kiyosawa; Y Imai; G Kaneko; T Kuroda; K Hashizume; R Y Osamura; H Katakami
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

Review 3.  Combined sellar gangliocytoma and pituitary adenoma in acromegaly or Cushing's disease. A report of 3 cases.

Authors:  W Saeger; M J Puchner; D K Lüdecke
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

Review 4.  Multiple endocrine neoplasia type 1 (MEN 1) revisited.

Authors:  B Padberg; S Schröder; C Capella; A Frilling; G Klöppel; P U Heitz
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.